DDR1 and cancer: Cancer cells harbor specific DDR deficiency, and thus, depend on a particular DDR regulator or pathway to deal with both endogenous and exogenous DNA damage for survival, thereby providing rational evidence to target these preponderance pathways with a more approchable therapeutic window in cancer [11–13].